Seven Arizona bioscience startups to watch in 2022

A regenerative treatment for Alzheimer’s disease, a respiratory-assist device to improve COPD patient care, a blood-based test for colorectal cancer, and a treatment to solve bad dog breath are some of the transformative advances of the 2022 Flinn Foundation Bioscience Entrepreneurship Program participants.

The seven Arizona-based, early-stage companies competitively selected for the foundation’s program will receive $30,000 in funding support through a nonprofit partner, a personalized learning plan, and connections with the state’s bioscience leaders in business, research, and policy.

The 2022 program participants include three Tucson-based startups, two from Phoenix and one each from Scottsdale and Surprise.

“These seven companies are working on innovations and treatments that could dramatically improve millions of lives and make for a healthier world—even for our pets,” said Tammy McLeod, Flinn Foundation president and CEO. “The Flinn Foundation program provides these entrepreneurs with the tools they will need to continue to grow their firms and attract investors.”

To learn more abou tthe 2022 Flinn Foundation Bioscience Entrepreneurship Program participants, click here.